Delivery Order SPE2DB20D3304-SPE2DB24FW5E2
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $6,842.00, is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The delivery order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,044.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $11,950.60 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,052.60, is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.0.5 ML, a pharmaceutical product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $37,452.40 for the supply of 4563971703 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,368.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4564360612 - TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with an ultimate completion date of April 23, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, including the Department of Defense and Department of Veterans...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $7,339.60 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialty pharmaceutical product. The award has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract, valued at $3,346.89, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $10,375.22 order is for the supply of 4563979947 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for delivering pharmaceuticals and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW5E2Delivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialty pharmaceutical product, with a potential value of $12,298.44 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 2/5/24 |